High-flow nasal oxygen: benefits are hard to show in COVID-19 patients with mild hypoxaemia.

Thille, Arnaud W; Frat, Jean-Pierre

Thille, Arnaud W; Frat, Jean-Pierre.

Thille AW; Médecine Intensive Réanimation, Centre Hospitalier Universitaire de Poitiers, Poitiers, France aw.thille@gmail.com.
Frat JP; INSERM CIC 1402, IS-ALIVE research group, Université de Poitiers UFR Médecine et Pharmacie, Poitiers, France.

Thorax ; 78(4): 321-322, 2023 04.

Article in English | MEDLINE | ID: covidwho-2283987

Subject(s)

COVID-19; Respiration Disorders; Respiratory Insufficiency; Humans; Oxygen; Hypoxia/etiology; Hypoxia/therapy; Oxygen Inhalation Therapy; Respiratory Insufficiency/therapy

Keywords

Critical Care; Respiratory Infection

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Respiration Disorders / Respiratory Insufficiency / COVID-19 Type of study: Etiology study Limits: Humans Language: English Journal: Thorax Year: 2023 Document Type: Article Affiliation country: Thorax-2022-219156

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google